TY - JOUR AU - Stupp, R. AU - Mason, W. P. AU - Bent, M. J. AU - Weller, M. AU - Fisher, B. AU - Taphoorn, M. J. PY - 2005 DA - 2005// TI - Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043330 DO - 10.1056/NEJMoa043330 ID - Stupp2005 ER - TY - JOUR AU - Yu, Y. AU - Kovacevic, Z. AU - Richardson, D. R. PY - 2007 DA - 2007// TI - Tuning cell cycle regulation with an iron key JO - Cell Cycle VL - 6 UR - https://doi.org/10.4161/cc.6.16.4603 DO - 10.4161/cc.6.16.4603 ID - Yu2007 ER - TY - JOUR AU - Kalinowski, D. S. AU - Richardson, D. R. PY - 2005 DA - 2005// TI - The evolution of iron chelators for the treatment of iron overload disease and cancer JO - Pharmacol Rev VL - 57 UR - https://doi.org/10.1124/pr.57.4.2 DO - 10.1124/pr.57.4.2 ID - Kalinowski2005 ER - TY - JOUR AU - Rouault, T. A. PY - 2013 DA - 2013// TI - Iron metabolism in the CNS: implications for neurodegenerative diseases JO - Nat Rev Neurosci VL - 14 UR - https://doi.org/10.1038/nrn3453 DO - 10.1038/nrn3453 ID - Rouault2013 ER - TY - JOUR AU - Neufeld, E. J. PY - 2006 DA - 2006// TI - Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2006-02-002394 DO - 10.1182/blood-2006-02-002394 ID - Neufeld2006 ER - TY - JOUR AU - Blatt, J. AU - Stitely, S. PY - 1987 DA - 1987// TI - Antineuroblastoma activity of desferoxamine in human cell lines JO - Cancer Res VL - 47 ID - Blatt1987 ER - TY - JOUR AU - Blatt, J. AU - Taylor, S. R. AU - Kontoghiorghes, G. J. PY - 1989 DA - 1989// TI - Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines JO - Cancer Res VL - 49 ID - Blatt1989 ER - TY - JOUR AU - Blatt, J. PY - 1994 DA - 1994// TI - Deferoxamine in children with recurrent neuroblastoma JO - Anticancer Res VL - 14 ID - Blatt1994 ER - TY - JOUR AU - Donfrancesco, A. AU - Deb, G. AU - Dominici, C. AU - Pileggi, D. AU - Castello, M. A. AU - Helson, L. PY - 1990 DA - 1990// TI - Effects of a single course of deferoxamine in neuroblastoma patients JO - Cancer Res VL - 50 ID - Donfrancesco1990 ER - TY - JOUR AU - Selig, R. A. AU - White, L. AU - Gramacho, C. AU - Sterling-Levis, K. AU - Fraser, I. W. AU - Naidoo, D. PY - 1998 DA - 1998// TI - Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts JO - Cancer Res VL - 58 ID - Selig1998 ER - TY - JOUR AU - Bedford, M. R. AU - Ford, S. J. AU - Horniblow, R. D. AU - Iqbal, T. H. AU - Tselepis, C. PY - 2013 DA - 2013// TI - Iron chelation in the treatment of cancer: a new role for deferasirox? JO - J Clin Pharmacol VL - 53 UR - https://doi.org/10.1002/jcph.113 DO - 10.1002/jcph.113 ID - Bedford2013 ER - TY - JOUR AU - Evans, S. M. AU - Judy, K. D. AU - Dunphy, I. AU - Jenkins, W. T. AU - Nelson, P. T. AU - Collins, R. PY - 2004 DA - 2004// TI - Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2424 DO - 10.1158/0008-5472.CAN-03-2424 ID - Evans2004 ER - TY - JOUR AU - Naidu, M. D. AU - Mason, J. M. AU - Pica, R. V. AU - Fung, H. AU - Pena, L. A. PY - 2010 DA - 2010// TI - Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1 JO - J Radiat Res VL - 51 UR - https://doi.org/10.1269/jrr.09077 DO - 10.1269/jrr.09077 ID - Naidu2010 ER - TY - JOUR AU - Rong, Y. AU - Durden, D. L. AU - Meir, E. G. AU - Brat, D. J. PY - 2006 DA - 2006// TI - ‘Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis JO - J Neuropathol Exp Neurol VL - 65 UR - https://doi.org/10.1097/00005072-200606000-00001 DO - 10.1097/00005072-200606000-00001 ID - Rong2006 ER - TY - JOUR AU - Spence, A. M. AU - Muzi, M. AU - Swanson, K. R. AU - O’Sullivan, F. AU - Rockhill, J. K. AU - Rajendran, J. G. PY - 2008 DA - 2008// TI - Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4995 DO - 10.1158/1078-0432.CCR-07-4995 ID - Spence2008 ER - TY - JOUR AU - Hoepken, H. H. AU - Korten, T. AU - Robinson, S. R. AU - Dringen, R. PY - 2004 DA - 2004// TI - Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate JO - J Neurochem VL - 88 UR - https://doi.org/10.1046/j.1471-4159.2003.02236.x DO - 10.1046/j.1471-4159.2003.02236.x ID - Hoepken2004 ER - TY - JOUR AU - Wilson, W. R. AU - Hay, M. P. PY - 2011 DA - 2011// TI - Targeting hypoxia in cancer therapy JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3064 DO - 10.1038/nrc3064 ID - Wilson2011 ER - TY - JOUR AU - Yang, L. P. AU - Keam, S. J. AU - Keating, G. M. PY - 2007 DA - 2007// TI - Deferasirox : a review of its use in the management of transfusional chronic iron overload JO - Drugs VL - 67 UR - https://doi.org/10.2165/00003495-200767150-00007 DO - 10.2165/00003495-200767150-00007 ID - Yang2007 ER - TY - JOUR AU - Zheng, H. AU - Youdim, M. B. AU - Fridkin, M. PY - 2010 DA - 2010// TI - Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities JO - ACS Chem Neurosci VL - 1 UR - https://doi.org/10.1021/cn100069c DO - 10.1021/cn100069c ID - Zheng2010 ER - TY - JOUR AU - Corce, V. AU - Renaud, S. AU - Cannie, I. AU - Julienne, K. AU - Gouin, S. G. AU - Loreal, O. PY - 2014 DA - 2014// TI - Synthesis and biological properties of Quilamines II, new iron chelators with antiproliferative activities JO - Bioconjug Chem VL - 25 UR - https://doi.org/10.1021/bc4004734 DO - 10.1021/bc4004734 ID - Corce2014 ER - TY - JOUR AU - Semenza, G. L. PY - 2012 DA - 2012// TI - Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy JO - Trends Pharmacol Sci VL - 33 UR - https://doi.org/10.1016/j.tips.2012.01.005 DO - 10.1016/j.tips.2012.01.005 ID - Semenza2012 ER - TY - JOUR AU - Elstner, A. AU - Holtkamp, N. AU - Deimling, A. PY - 2007 DA - 2007// TI - Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells JO - Clin Exp Metastasis VL - 24 UR - https://doi.org/10.1007/s10585-007-9057-y DO - 10.1007/s10585-007-9057-y ID - Elstner2007 ER - TY - JOUR AU - Weitman, S. D. AU - Buchanan, G. R. AU - Kamen, B. A. PY - 1991 DA - 1991// TI - Pulmonary toxicity of deferoxamine in children with advanced cancer JO - J Natl Cancer Inst VL - 83 UR - https://doi.org/10.1093/jnci/83.24.1834b DO - 10.1093/jnci/83.24.1834b ID - Weitman1991 ER - TY - JOUR AU - Beerepoot, L. V. AU - Shima, D. T. AU - Kuroki, M. AU - Yeo, K. T. AU - Voest, E. E. PY - 1996 DA - 1996// TI - Up-regulation of vascular endothelial growth factor production by iron chelators JO - Cancer Res VL - 56 ID - Beerepoot1996 ER - TY - JOUR AU - Schonberg, D. L. AU - Miller, T. E. AU - Wu, Q. AU - Flavahan, W. A. AU - Das, N. K. AU - Hale, J. S. PY - 2015 DA - 2015// TI - Preferential iron trafficking characterizes glioblastoma stem-like cells JO - Cancer Cell VL - 28 UR - https://doi.org/10.1016/j.ccell.2015.09.002 DO - 10.1016/j.ccell.2015.09.002 ID - Schonberg2015 ER - TY - JOUR AU - Lathia, J. D. AU - Mack, S. C. AU - Mulkearns-Hubert, E. E. AU - Valentim, C. L. AU - Rich, J. N. PY - 2015 DA - 2015// TI - Cancer stem cells in glioblastoma JO - Genes Dev VL - 29 UR - https://doi.org/10.1101/gad.261982.115 DO - 10.1101/gad.261982.115 ID - Lathia2015 ER - TY - JOUR AU - Burgo, L. S. AU - Hernandez, R. M. AU - Orive, G. AU - Pedraz, J. L. PY - 2014 DA - 2014// TI - Nanotherapeutic approaches for brain cancer management JO - Nanomedicine VL - 10 UR - https://doi.org/10.1016/j.nano.2013.10.001 DO - 10.1016/j.nano.2013.10.001 ID - Burgo2014 ER - TY - JOUR AU - Serwer, L. P. AU - James, C. D. PY - 2012 DA - 2012// TI - Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations JO - Adv Drug Deliv Rev VL - 64 UR - https://doi.org/10.1016/j.addr.2012.01.004 DO - 10.1016/j.addr.2012.01.004 ID - Serwer2012 ER - TY - JOUR AU - Kamalinia, G. AU - Khodagholi, F. AU - Atyabi, F. AU - Amini, M. AU - Shaerzadeh, F. AU - Sharifzadeh, M. PY - 2013 DA - 2013// TI - Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies JO - Mol Pharm VL - 10 UR - https://doi.org/10.1021/mp4002014 DO - 10.1021/mp4002014 ID - Kamalinia2013 ER - TY - JOUR AU - Liu, G. AU - Men, P. AU - Harris, P. L. AU - Rolston, R. K. AU - Perry, G. AU - Smith, M. A. PY - 2006 DA - 2006// TI - Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance JO - Neurosci Lett VL - 406 UR - https://doi.org/10.1016/j.neulet.2006.07.020 DO - 10.1016/j.neulet.2006.07.020 ID - Liu2006 ER - TY - JOUR AU - Liu, G. AU - Men, P. AU - Kudo, W. AU - Perry, G. AU - Smith, M. A. PY - 2009 DA - 2009// TI - Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease JO - Neurosci Lett VL - 455 UR - https://doi.org/10.1016/j.neulet.2009.03.064 DO - 10.1016/j.neulet.2009.03.064 ID - Liu2009 ER - TY - JOUR AU - Heath, J. L. AU - Weiss, J. M. AU - Lavau, C. P. AU - Wechsler, D. S. PY - 2014 DA - 2014// TI - Effects of iron depletion on CALM-AF10 leukemias JO - Exp Hematol VL - 42 UR - https://doi.org/10.1016/j.exphem.2014.08.004 DO - 10.1016/j.exphem.2014.08.004 ID - Heath2014 ER - TY - JOUR AU - Pullarkat, V. AU - Meng, Z. AU - Donohue, C. AU - Yamamoto, V. N. AU - Tomassetti, S. AU - Bhatia, R. PY - 2014 DA - 2014// TI - Iron chelators induce autophagic cell death in multiple myeloma cells JO - Leuk Res VL - 38 UR - https://doi.org/10.1016/j.leukres.2014.06.005 DO - 10.1016/j.leukres.2014.06.005 ID - Pullarkat2014 ER - TY - JOUR AU - Paubelle, E. AU - Zylbersztejn, F. AU - Alkhaeir, S. AU - Suarez, F. AU - Callens, C. AU - Dussiot, M. PY - 2013 DA - 2013// TI - Deferasirox and vitamin D improves overall survival in elderly patients with acute myeloid leukemia after demethylating agents failure JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0065998 DO - 10.1371/journal.pone.0065998 ID - Paubelle2013 ER - TY - JOUR AU - Lee, D. H. AU - Jang, P. S. AU - Chung, N. G. AU - Cho, B. AU - Jeong, D. C. AU - Kim, H. K. PY - 2013 DA - 2013// TI - Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status JO - Exp Hematol VL - 41 UR - https://doi.org/10.1016/j.exphem.2013.02.004 DO - 10.1016/j.exphem.2013.02.004 ID - Lee2013 ER - TY - JOUR AU - Fukushima, T. AU - Kawabata, H. AU - Nakamura, T. AU - Iwao, H. AU - Nakajima, A. AU - Miki, M. PY - 2011 DA - 2011// TI - Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia JO - Anticancer Res VL - 31 ID - Fukushima2011 ER - TY - JOUR AU - Kim, J. L. AU - Kang, H. N. AU - Kang, M. H. AU - Yoo, Y. A. AU - Kim, J. S. AU - Choi, C. W. PY - 2011 DA - 2011// TI - The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase JO - Acta Haematol VL - 126 UR - https://doi.org/10.1159/000330608 DO - 10.1159/000330608 ID - Kim2011 ER - TY - JOUR AU - Messa, E. AU - Carturan, S. AU - Maffe, C. AU - Pautasso, M. AU - Bracco, E. AU - Roetto, A. PY - 2010 DA - 2010// TI - Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging JO - Haematologica VL - 95 UR - https://doi.org/10.3324/haematol.2009.016824 DO - 10.3324/haematol.2009.016824 ID - Messa2010 ER - TY - JOUR AU - Ohyashiki, J. H. AU - Kobayashi, C. AU - Hamamura, R. AU - Okabe, S. AU - Tauchi, T. AU - Ohyashiki, K. PY - 2009 DA - 2009// TI - The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1 JO - Cancer Sci VL - 100 UR - https://doi.org/10.1111/j.1349-7006.2009.01131.x DO - 10.1111/j.1349-7006.2009.01131.x ID - Ohyashiki2009 ER - TY - JOUR AU - Ford, S. J. AU - Bedford, M. R. AU - Pang, W. AU - Wood, A. AU - Iqbal, T. AU - Tselepis, C. PY - 2014 DA - 2014// TI - A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy JO - Ann R Coll Surg Engl VL - 96 UR - https://doi.org/10.1308/003588414X13946184900282 DO - 10.1308/003588414X13946184900282 ID - Ford2014 ER - TY - JOUR AU - Ford, S. J. AU - Obeidy, P. AU - Lovejoy, D. B. AU - Bedford, M. AU - Nichols, L. AU - Chadwick, C. PY - 2013 DA - 2013// TI - Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo JO - Br J Pharmacol VL - 168 UR - https://doi.org/10.1111/bph.12045 DO - 10.1111/bph.12045 ID - Ford2013 ER - TY - JOUR AU - Vazana-Barad, L. AU - Granot, G. AU - Mor-Tzuntz, R. AU - Levi, I. AU - Dreyling, M. AU - Nathan, I. PY - 2013 DA - 2013// TI - Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2012.734614 DO - 10.3109/10428194.2012.734614 ID - Vazana-Barad2013 ER - TY - JOUR AU - Choi, J. G. AU - Kim, J. L. AU - Park, J. AU - Lee, S. AU - Park, S. J. AU - Kim, J. S. PY - 2012 DA - 2012// TI - Effects of oral iron chelator deferasirox on human malignant lymphoma cells JO - Korean J Hematol VL - 47 UR - https://doi.org/10.5045/kjh.2012.47.3.194 DO - 10.5045/kjh.2012.47.3.194 ID - Choi2012 ER - TY - JOUR AU - Lui, G. Y. AU - Obeidy, P. AU - Ford, S. J. AU - Tselepis, C. AU - Sharp, D. M. AU - Jansson, P. J. PY - 2013 DA - 2013// TI - The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action JO - Mol Pharmacol VL - 83 UR - https://doi.org/10.1124/mol.112.081893 DO - 10.1124/mol.112.081893 ID - Lui2013 ER - TY - JOUR AU - Song, S. AU - Christova, T. AU - Perusini, S. AU - Alizadeh, S. AU - Bao, R. Y. AU - Miller, B. W. PY - 2011 DA - 2011// TI - Wnt inhibitor screen reveals iron dependence of beta-catenin signaling in cancers JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-2745 DO - 10.1158/0008-5472.CAN-11-2745 ID - Song2011 ER - TY - JOUR AU - Gaboriau, F. AU - Leray, A. M. AU - Ropert, M. AU - Gouffier, L. AU - Cannie, I. AU - Troadec, M. B. PY - 2010 DA - 2010// TI - Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG JO - Biometals VL - 23 UR - https://doi.org/10.1007/s10534-009-9281-9 DO - 10.1007/s10534-009-9281-9 ID - Gaboriau2010 ER - TY - JOUR AU - Lescoat, G. AU - Chantrel-Groussard, K. AU - Pasdeloup, N. AU - Nick, H. AU - Brissot, P. AU - Gaboriau, F. PY - 2007 DA - 2007// TI - Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism JO - Cell Prolif VL - 40 UR - https://doi.org/10.1111/j.1365-2184.2007.00468.x DO - 10.1111/j.1365-2184.2007.00468.x ID - Lescoat2007 ER - TY - JOUR AU - Chantrel-Groussard, K. AU - Gaboriau, F. AU - Pasdeloup, N. AU - Havouis, R. AU - Nick, H. AU - Pierre, J. L. PY - 2006 DA - 2006// TI - The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox JO - Eur J Pharmacol VL - 541 UR - https://doi.org/10.1016/j.ejphar.2006.05.001 DO - 10.1016/j.ejphar.2006.05.001 ID - Chantrel-Groussard2006 ER -